Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID-19 in Thai patients.
Nithita NanthatantiSithakom PhusantiPichika ChantrathammachartKanin ThammavaranucuptPantep AngchaisuksiriSomnuek SungkanuparphPublished in: Research and practice in thrombosis and haemostasis (2020)
Thrombosis in COVID-19 is increasingly recognized and is generally associated with a high mortality rate. The key clinical question of this report was whether COVID-19 could be complicated with cardiac thrombus and pulmonary embolism in Asian population. We demonstrated the case series of thrombosis in Thai patients with confirmed severe acute respiratory syndrome coronavirus 2 infection. One patient had the first case of a large left ventricular thrombus, and three other patients had pulmonary embolism. All patients were male and had low absolute lymphocyte count, while lactate dehydrogenase level and d-dimer were markedly elevated, especially at the time when the thrombosis was diagnosed. All patients had severe COVID-19 with pneumonia. Two patients who needed mechanical ventilation were successfully extubated. After hospitalization for 13-49 days, pneumonia and thrombosis improved and all of them could be discharged from the hospital. Thrombosis is common in COVID-19 and could present in both arterial and venous sites even in Asian populations. d-dimer is a strong marker to predict thrombosis and could be a prognostic predictor for severity of COVID-19.
Keyphrases
- pulmonary embolism
- coronavirus disease
- sars cov
- end stage renal disease
- inferior vena cava
- left ventricular
- ejection fraction
- respiratory syndrome coronavirus
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- mechanical ventilation
- heart failure
- type diabetes
- emergency department
- intensive care unit
- acute myocardial infarction
- acute respiratory distress syndrome
- acute coronary syndrome
- atrial fibrillation
- hypertrophic cardiomyopathy
- left atrial
- drug induced